JP Stock MarketDetailed Quotes

Prism Biolab (206A)

Watchlist
  • 171
  • +3+1.79%
20min DelayMarket Closed May 15 15:30 JST
6.32BMarket Cap-7.49P/E (Static)

Prism Biolab (206A) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(FY)Sep 30, 2024
(FY)Sep 30, 2023
(FY)Sep 30, 2022
Operating cash flow (Indirect Method)
Cash from operating activities
-1,073.44%-1.47B
129.46%151.13M
-592.95%-513M
104.07M
Net profit before non-cash adjustment
20.69%-831.28M
-99.39%-1.05B
-808.91%-525.7M
--74.16M
Total adjustment of non-cash items
-91.94%25.36M
866.65%314.82M
1,023.39%32.57M
---3.53M
-Depreciation and amortization
----
--0
623.26%8.74M
--1.21M
-Reversal of impairment losses recognized in profit and loss
-61.70%82.98M
669.53%216.63M
524.47%28.15M
--4.51M
-Disposal profit
--0
-5,050.00%-99K
--2K
--0
-Net exchange gains and losses
-252.44%-27.34M
13,095.65%17.93M
98.68%-138K
---10.49M
-Remuneration paid in stock
--5.47M
--0
----
----
-Other non-cash items
-144.48%-35.74M
2,020.48%80.35M
-436.60%-4.18M
--1.24M
Changes in working capital
-175.21%-665.21M
4,552.38%884.51M
-159.42%-19.87M
--33.44M
-Change in receivables
----
--0
206.42%21.72M
---20.41M
-Change in prepaid assets
-117.47%-23.33M
-330.42%-10.73M
468.38%4.66M
--819K
-Change in payables
-66.38%6.64M
140.02%19.75M
-50.27%8.23M
--16.55M
-Change in accrued expense
--0
25.25%3.22M
114.17%2.57M
--1.2M
-Provision for loans, leases and other losses
--12.89M
--0
----
----
-Changes in other current assets
-175.83%-661.41M
1,629.19%872.27M
-261.68%-57.04M
--35.28M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)
1,421.89%4.03M
1,294.74%265K
-9.52%19K
21K
Tax refund paid
-1.84%-1.27M
-3.14%-1.25M
0.25%-1.21M
-1.21M
Other operating cash inflow (outflow)
1K
0
338.37%377K
86K
Operating cash flow
-1,077.97%-1.47B
129.22%150.14M
-599.03%-513.81M
--102.96M
Investing cash flow
Net PPE purchase and sale
68.55%-64.7M
-494.71%-205.72M
-505.06%-34.59M
---5.72M
Net intangibles purchase and sale
49.48%-2.99M
---5.91M
--0
----
Net changes in other investments
95.92%-1.33M
-462.74%-32.56M
-168.24%-5.79M
---2.16M
Investing cash flow
71.74%-69.01M
-504.77%-244.19M
-412.79%-40.38M
---7.87M
Financing cash flow
Net common stock issuance
-99.01%33.59M
--3.39B
--0
--210.87M
Issuance fees
--0
---20.85M
--0
----
Net other fund-raising expenses
200.00%1K
---1K
----
---100M
Financing cash flow
-99.00%33.59M
--3.37B
--0
--110.87M
Net cash flow
Beginning cash position
287.32%4.39B
-32.82%1.13B
14.71%1.69B
--1.47B
Current changes in cash
-145.90%-1.5B
691.14%3.28B
-369.08%-554.19M
--205.96M
Effect of exchange rate changes
252.44%27.34M
-13,095.65%-17.93M
-98.68%138K
--10.49M
Cash adjustments other than cash changes
----
--1K
----
--1K
End cash Position
-33.62%2.92B
287.32%4.39B
-32.82%1.13B
--1.69B
Free cash flow
-2,395.49%-1.54B
88.78%-61.55M
-663.94%-548.4M
--97.25M
Currency Unit
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Sep 30, 2025(FY)Sep 30, 2024(FY)Sep 30, 2023(FY)Sep 30, 2022
Operating cash flow (Indirect Method)
Cash from operating activities -1,073.44%-1.47B129.46%151.13M-592.95%-513M104.07M
Net profit before non-cash adjustment 20.69%-831.28M-99.39%-1.05B-808.91%-525.7M--74.16M
Total adjustment of non-cash items -91.94%25.36M866.65%314.82M1,023.39%32.57M---3.53M
-Depreciation and amortization ------0623.26%8.74M--1.21M
-Reversal of impairment losses recognized in profit and loss -61.70%82.98M669.53%216.63M524.47%28.15M--4.51M
-Disposal profit --0-5,050.00%-99K--2K--0
-Net exchange gains and losses -252.44%-27.34M13,095.65%17.93M98.68%-138K---10.49M
-Remuneration paid in stock --5.47M--0--------
-Other non-cash items -144.48%-35.74M2,020.48%80.35M-436.60%-4.18M--1.24M
Changes in working capital -175.21%-665.21M4,552.38%884.51M-159.42%-19.87M--33.44M
-Change in receivables ------0206.42%21.72M---20.41M
-Change in prepaid assets -117.47%-23.33M-330.42%-10.73M468.38%4.66M--819K
-Change in payables -66.38%6.64M140.02%19.75M-50.27%8.23M--16.55M
-Change in accrued expense --025.25%3.22M114.17%2.57M--1.2M
-Provision for loans, leases and other losses --12.89M--0--------
-Changes in other current assets -175.83%-661.41M1,629.19%872.27M-261.68%-57.04M--35.28M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities) 1,421.89%4.03M1,294.74%265K-9.52%19K21K
Tax refund paid -1.84%-1.27M-3.14%-1.25M0.25%-1.21M-1.21M
Other operating cash inflow (outflow) 1K0338.37%377K86K
Operating cash flow -1,077.97%-1.47B129.22%150.14M-599.03%-513.81M--102.96M
Investing cash flow
Net PPE purchase and sale 68.55%-64.7M-494.71%-205.72M-505.06%-34.59M---5.72M
Net intangibles purchase and sale 49.48%-2.99M---5.91M--0----
Net changes in other investments 95.92%-1.33M-462.74%-32.56M-168.24%-5.79M---2.16M
Investing cash flow 71.74%-69.01M-504.77%-244.19M-412.79%-40.38M---7.87M
Financing cash flow
Net common stock issuance -99.01%33.59M--3.39B--0--210.87M
Issuance fees --0---20.85M--0----
Net other fund-raising expenses 200.00%1K---1K-------100M
Financing cash flow -99.00%33.59M--3.37B--0--110.87M
Net cash flow
Beginning cash position 287.32%4.39B-32.82%1.13B14.71%1.69B--1.47B
Current changes in cash -145.90%-1.5B691.14%3.28B-369.08%-554.19M--205.96M
Effect of exchange rate changes 252.44%27.34M-13,095.65%-17.93M-98.68%138K--10.49M
Cash adjustments other than cash changes ------1K------1K
End cash Position -33.62%2.92B287.32%4.39B-32.82%1.13B--1.69B
Free cash flow -2,395.49%-1.54B88.78%-61.55M-663.94%-548.4M--97.25M
Currency Unit JPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More